.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2015 for a whopping $43 bil...
.On the heels of a phase 3 gain that stopped working to thrill clients, Ironwood Pharmaceuticals is ...
.Don't stop Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball af...
.Welcome to recently's Chutes & Ladders, our roundup of significant leadership hirings, firings a...
.Celebrating his firm's upsized going public (IPO), Septerna chief executive officer Jeffrey Finer c...
.AbbVie has gone back to the source of its own antipsychotic powerhouse Vraylar searching for yet an...
.GenSight Biologics is actually weeks off of running out of loan. Once more. The biotech merely poss...
.Monopar Rehabs is actually recuperating a medication from the dump of AstraZeneca's unusual health ...
.With brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of analys...
.After creating a genetics treatment alliance with Dyno Rehabs in 2020, Roche is actually back for e...